The move is designed to keep the doors of the clinic open, and is a reflection of the increasingly blurred lines between the beauty industry and health care. By Alisha Haridasani Gupta Last week, the ...
Solid Biosciences (SLDB) stock dips after new Phase 1/2 trial data for SGT-003, its gene therapy for Duchenne muscular dystrophy. Read more here, ...
"Always pay attention, no matter how trained your dog is, because it only takes a second," owner Kylie Dixon told Newsweek.
A single infusion of stem cells helped frail older adults walk significantly farther.
NMC warns medical colleges of rejecting applications for extra seats if caught admitting fake patients during assessments.
IV hydration lounges and mobile “drip therapy” services have rapidly expanded across Florida, promising quick recovery from dehydration, fatigue, and illness through vitamin and fluid infusions ...
MedPage Today on MSN
Matching Drug to Bug Is Crucial to Treat Prosthetic Joint Infections
Three studies highlight ways to improve outcomes for vexing problem ...
Unless Kay Ivey, the governor of Alabama, decides to commute Mr. Burton’s sentence, the state is set to kill him on March 12.
Severe cases may need oxygen, IV fluids or corticosteroids. Antibiotics don’t work since they are to combat bacteria, and ...
SGT-003 in the INSPIRE DUCHENNE trial to date - - Robust microdystrophin expression with consistent mechanistic evidence of dystrophin associated protein complex (DAPC) restoration and improvements in ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Wednesday, March 11, 2026. Let’s ...
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage biotechnology company developing transformative therapies for the treatment of cancer and rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results